These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 606306)

  • 1. Normal active rosette-forming-cells in untreated patients with Hodgkin's disease.
    Lang JM; Bigel P; Oberling F; Mayer S
    Biomedicine; 1977 Dec; 27(9-10):322-4. PubMed ID: 606306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E-rosette inhibiting substance in Hodgkin's disease spleen extracts.
    Bieber MM; Fuks Z; Kaplan HS
    Clin Exp Immunol; 1977 Sep; 29(3):369-75. PubMed ID: 201408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cellular immunity in patients with Hodgkin's disease: modification induced by incubating lymphocytes with fetal calf serum and Hodgkin's serum].
    Rambotti P; Velardi A; Spinozzi F; Falini B; Martelli MF
    Boll Ist Sieroter Milan; 1979 Mar; 58(1):90-9. PubMed ID: 552840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiosensitivity of Hodgkin's disease lymphocytes.
    Baral E; Blomgren H; Rotstein S
    J Clin Lab Immunol; 1981 Mar; 5(2):101-5. PubMed ID: 7218327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hodgkin's disease. T lymphocyte defect in patients in complete remission (author's transl)].
    Lang JM; Bigel P; Oberling F; Mayer S
    Pathol Biol (Paris); 1978; 26(3-4):159-62. PubMed ID: 355984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hodgkin's disease. T lymphocyte defect in patients in complete remission (author's transl)].
    Lang JM; Bigel P; Oberling F; Mayer S
    Sem Hop; 1978 Nov 8-15; 54(37-40):1155-8. PubMed ID: 217096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro stimulation of T-cell rosette formation by antiserum to thymus factor in Hodgkin's disease.
    Zółtowska A; Arendt M; Gan J
    Arch Immunol Ther Exp (Warsz); 1984; 32(1):51-7. PubMed ID: 6332594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of levamisole, thymic humoral factor and indomethacin on e-rosette formation of lymphocytes in Hodgkin's disease.
    Ramot B; Rosenthal E; Biniaminov M; Ben-Bassat I
    Isr J Med Sci; 1981 Apr; 17(4):232-5. PubMed ID: 7195385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between serum factors and T lymphocytes in Hodgkin's disease. Use as a diagnostic test.
    Fuks Z; Strober S; Kaplan HS
    N Engl J Med; 1976 Dec; 295(23):1273-8. PubMed ID: 185517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of cell surface abnormalities of T lymphocytes in hodgkin's disease after in vitro incubation in fetal sera.
    Fuks Z; Strober S; King DP; Kaplan HS
    J Immunol; 1976 Oct; 117(4):1331-5. PubMed ID: 1086325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ferritin-bearing lymphocytes in Hodgkin's disease.
    Koprivová H; Hermanská Z; Novák F; Blehová Z; Dienstbier Z
    Neoplasma; 1986; 33(1):63-9. PubMed ID: 3515213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Persisting deficiency of cell mediated immunity in Hodgkin's disease in complete remission (author's transl)].
    Lang JM; Bigel P; Giron C; Faradji A; Oberling F; Mayer S
    Nouv Presse Med; 1979 Nov; 8(44):3629-32. PubMed ID: 316521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E rosettes in lymphoproliferative diseases.
    Benesová E; Hermanský F; Sálková J
    Neoplasma; 1976; 23(1):23-30. PubMed ID: 1083961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PHA dose dependent defect in lymphocyte stimulation and E-rosette-forming cells in untreated Hodgkin's disease.
    Land JM; Litwin J; Bigel P; Oberling F; Mayer S
    Acta Haematol Pol; 1977; 8(2):131-4. PubMed ID: 329629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rosette-forming cells in patients with treated leprosy.
    Dang DT; Pham MH; Hoang TL; Lai VG; Nguyen HH
    Int J Lepr Other Mycobact Dis; 1983 Jun; 51(2):174-8. PubMed ID: 6684644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autologous rosette-forming capacity of T-lymphocytes in Hodgkin's disease.
    Bodolay E; Berényi E; Sonkoly I; Szegedi G
    Acta Med Hung; 1984; 41(2-3):113-9. PubMed ID: 6611543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inhibitory action of Hodgkin's disease patients serum on T lymphocytes E rosette forming ability (author's transl)].
    Panteghini M; Piccioli E; Migliorati T; Ruggeri G
    Ann Sclavo; 1979; 21(4):483-93. PubMed ID: 317987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Active T-rosette-forming cells in the peripheral blood of cancer patients.
    Kerman RH; Smith R; Stefani SS; Ezdinili EZ
    Cancer Res; 1976 Sep; 36(9 pt.1):3274-8. PubMed ID: 1086131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subpopulations of human T lymphocytes in patients with Hodgkin's disease before and after treatment.
    Karande AA; Gulwani B; Advani SH; Gangal SG
    Neoplasma; 1982; 29(2):149-59. PubMed ID: 6981068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formation of total and stable E-rosettes by lymphocytes from patients with pulmonary tuberculosis stimulated by Con A or PPD.
    Aristizábal L; García LF
    J Clin Lab Immunol; 1985 Jan; 16(1):31-6. PubMed ID: 3981616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.